Membrane-bound transcription factor site-2 protease (S2P)

Membrane-bound transcription factor site-2 protease (S2P), encoded by the *MBTPS2* gene on chromosome Xp22.1-p22.2, is an integral membrane zinc metalloprotease that catalyzes intramembrane cleavage within transmembrane helices of substrate proteins[3][6]. It performs the second step ("site 2") cleavage following initial "site 1" cleavage by another protease during regulated intramembrane proteolysis—a conserved signaling mechanism across all domains of life[4]. In mammals, its primary known substrates include sterol regulatory element-binding proteins (SREBP1/2), which regulate cholesterol/lipid biosynthesis genes upon activation by sequential cleavage releasing their N-terminal active fragments into the nucleus[1][3]. It also cleaves other membrane-tethered transcription factors like ATF6 involved in endoplasmic reticulum stress response[1][6]. Mutations reducing human S2P function cause diverse pathologies ranging from skin abnormalities to neurological defects due to impaired processing of key regulatory proteins[1][3]. In bacteria, homologous site-2-proteases regulate adaptive responses such as iron uptake systems and virulence traits by cleaving anti-sigma factors after prior processing by site-one-proteases; these processes enable environmental signal coupling with gene expression changes critical for survival under stress or during infection[5]. Due to its central role both physiologically and pathogenically—especially regarding lipid metabolism regulation in humans and virulence control in bacteria—S2P represents a promising but challenging therapeutic target with ongoing research interest focused on understanding substrate specificity mechanisms mediated partly through PDZ domain interactions found on some bacterial homologs[4]. This summary integrates molecular identity/classification along with biological roles relevant for therapeutic targeting considerations based on current scientific literature.[1][3][4][5][6]

Other names

S2P endopeptidasemembrane-bound transcription factor peptidase site 2MBTPS2 (gene symbol)site-2 protease

Drugs targeting this enzyme would likely inhibit its metalloprotease activity to prevent cleavage/activation of substrates like SREBPs or bacterial anti-sigma factors. This would block downstream signaling pathways dependent on regulated intramembrane proteolysis. In bacteria, inhibition could disrupt virulence factor release or stress responses. In humans, modulation could affect lipid metabolism or ER stress pathways. No specific drug mechanisms are yet clinically validated.